We are live on ! Find out more
GCVRZ

Sanofi Contingent Value Rights
GCVRZ

Delisted

GCVRZ was delisted on the 3rd of March, 2020.

Back to rankings

146 hedge funds and large institutions have $326M invested in Sanofi Contingent Value Rights in 2013 Q2 according to their latest regulatory filings, with 146 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
146
Holders Change
+146
Holders Change %
–
% of All Funds
4.75%
Holding in Top 10
5
Holding in Top 10 Change
+5
Holding in Top 10 Change %
% of All Funds
0.16%
New
146
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

GCVRZ Hedge Fund Activity: Q2 2013 in Review

146 of the 3,075 institutional investors tracked by Wall St. Rank reported a position in Sanofi Contingent Value Rights (GCVRZ) for Q2 2013, worth a combined $326M.

Buyers outnumbered sellers: 146 funds opened new GCVRZ positions and 0 closed out — a net gain of 146 holders — while 0 added to existing stakes and 0 trimmed.

  • 146 institutional investors held Sanofi Contingent Value Rights (GCVRZ) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $326M of Sanofi Contingent Value Rights stock for Q2 2013.
  • 146 funds opened new Sanofi Contingent Value Rights positions in Q2 2013 and 0 closed out, a net change of +146 holders.

Based on aggregated 13F filings for Q2 2013.